Author:
Du Wei,Fu Sha,Wang Yuhong,He Li na,Luo Lin feng,Wang Yi xing,Zhang Xuan Ye,Chen Chen,jiang yongluo,Zhou Yi xin,Zhang Li,Hong Shaodong
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference32 articles.
1. Pembrolizumab versus chemotherapy for previously untreated,PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): A randomised, open-label, controlled, phase 3 trial;T S K Mok;Lancet,2019
2. Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity;W J Lesterhuis;Nat. Rev. Drug Discov,2017
3. Mechanismdriven biomarkers to guide immune checkpoint blockade in cancer therapy;S L Topalian;Nat. Rev. Cancer,2016
4. Monitoring immunecheckpoint blockade: response evaluation and biomarker development;M Nishino;Nat. Rev. Clin. Oncol,2017
5. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy;J J Havel;Nat. Rev. Cancer,2019